Mr. Winowich is a recognized authority in all of the Artificial Heart Program's (AHP) core services, including the establishment of mechanical circulatory heart programs at adult and pediatric institutions; assisting with the training of more than 100 medical centers in the application of VAD technology; and contributing to both US based and international institutions in the primary clinical setting. He has been a member of the University of Pittsburgh Medical Center AHP for nearly 20 years and has participated in the care of over 375 VAD/TAH patients. Mr. Winowich assumed the role of Director of Clinical Bioengineering for UPMC in 1996. Mr. Winowich has exceptional understanding of the development of new technologies, as seen by his participation in the first ever HeartMate® II implant, service on the Data Safety and Monitoring Boards and clinical advisory committees for an array of circulatory support device manufacturers. He also serves on the Executive Committee of the McGowan Institute for Regenerative Medicine. Mr. Winowich earned his B.S. in Chemical Engineering from the University of Pittsburgh.